Research News and Research

RSS

Sebelius talks health insurance exchanges

Health and Human Services Secretary Kathleen Sebelius took questions from PBS Newshour viewers about these new health insurance marketplaces that were envisioned in the health law. Also in the news, analysis of the recess appointment of Centers for Medicare and Medicaid Services Director Donald Berwick and more about what implementation activities are happening at the state level.

12 Aug 2011

GOP lawmaker wants health IT study to focus on errors

Rep. Renee Ellmers, R-N.C., wrote a letter to Health and Human Services Secretary Kathleen Sebelius requesting that the nation's push for electronic medical records include a study of the medical error rates associated with this technology.

12 Aug 2011

With panelists now in place, possible dynamics of a deal emerge

The special committee that will have to find $1.5 trillion in budget savings has a few members who will understand exactly what's at stake for Medicare and Medicaid. But others will only have a general idea — and it may be completely shaped by their political interests. Some of them won't have much of a health care background at all, but will have to get up to speed quickly.

12 Aug 2011

More biodiversity needed to keep ecosystems functioning

The biological diversity of organisms on earth is not just something we enjoy when taking a walk through a blossoming meadow in spring; it is also the basis for countless products and services provided by nature, including food, building materials, and medicines as well as the self-purifying qualities of water and protection against erosion.

12 Aug 2011

Boston health organizations plan merger

Partners HealthCare and Neighborhood Health Plan sign letter of intent for merger. In other hospital issues, Parkland Hospital In Dallas is in danger of losing Medicare accreditation and Conn. regulators are criticized.

12 Aug 2011

Thorne acquires global rights to Q-Cell, an advanced formulation Coenzyme Q10

Thorne Research, Inc., a leader in developing and manufacturing pure, high quality nutritional supplements marketed through licensed healthcare practitioners, has acquired exclusive global rights to market Q-Cell, an advanced formulation Coenzyme Q10 (CoQ10) supplement formerly marketed under the brand name Q-Best.

12 Aug 2011

States slashing at least $4.7 billion from Medicaid plans

Reuters reports on a study of the state cuts by the Center on Budget and Policy Priorities. Also, Blue Cross Blue Shield of Michigan is looking to expand its Medicaid business and a California study explores the high number of young people without insurance.

12 Aug 2011

Teens involved in research studies prefer telephones over social media

If you think teenagers prefer social media over the telephone, you may want to think again, at least when it comes to teens involved in research studies.

12 Aug 2011

PLC Systems second quarter total revenues increase to $398,000

PLC Systems Inc., a company focused on innovative medical device technologies, today reported financial results for the three- and six month periods ended June 30, 2011. These results only include the company's RenalGuard® operations, since PLC completed the sale of its transmyocardial revascularization (TMR) business to Novadaq Corp. during the first quarter of 2011.

12 Aug 2011

Pelosi adds her picks to deficit reduction committee

With House Democratic Leader Nancy Pelosi's selections now made for the 'super committee,' the panel is complete. The next step: analyzing what positions they will bring to the negotiations and what the likelihood is that the group will strike a deal.

12 Aug 2011

Money now preferred to cocaine later

When a research team asked cocaine addicts to choose, hypothetically, between money now or cocaine of greater value later, "preference was almost exclusively for the money now," said Warren K., Bickel, professor in the Virginia Tech Carilion Research Institute, director of the Advanced Recovery Research Center, and professor of psychology in the College of Science at Virginia Tech.

12 Aug 2011

Galectin second quarter net loss increases to $3.9 million

Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the second quarter and first six months, ended June 30, 2011.

12 Aug 2011

Metabolic profile reveals need for gender-specific therapies

Analyses of the metabolic profile of blood serum reveal significant differences between men and women. From their tests, scientists at the Helmholtz Zentrum München have concluded that there is a need for gender-specific therapies. The study was financed by the German Centre for Diabetes Research and was published in the current edition of the internationally renowned peer-reviewjournal PLoS Genetics.

12 Aug 2011

Interleukin Genetics second quarter total revenue increases to $0.8 million

Interleukin Genetics, Inc. today announced financial and operational results for the second quarter ended June 30, 2011.

12 Aug 2011

Echo net loss for first half 2011 increases to $6.5 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced results for the period ended June 30, 2011.

12 Aug 2011

ShangPharma approves share repurchase program

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.

12 Aug 2011

First Edition: August 12, 2011

Kaiser Health News' Mary Agnes Carey and Politico Pro's David Nather talk to Jackie Judd about the now complete "super committee" and what it may mean for Medicare and Medicaid.

12 Aug 2011

Soligenix second quarter revenues decrease to $406,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2011.

12 Aug 2011

Sinovac second quarter sales increase 52.5% to $15.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2011.

12 Aug 2011

Study confirms ability of Tru-D device to decontaminate surfaces in patient rooms

In an original article coauthored by John M. Boyce, MD; Nancy L. Havill, MT; and Brent A. Moore, PhD, "Terminal Decontamination of Patient Rooms Using an Automated Mobile UV Light Unit", the research team from the Hospital of Saint Raphael and the Yale University School of Medicine ". . . demonstrated that an automated, portable UV light device significantly reduced aerobic colony counts on high-touch surfaces in patient rooms.

12 Aug 2011